|
MechanismTGF-β1 inhibitors |
|
|
|
|
Drug Highest PhasePhase 2 |
First Approval Ctry. / Loc.- |
First Approval Date- |
/ CompletedNot Applicable Randomized, double-blind, comparative clinical trial to evaluate the effectiveness of a dermo-cosmetic product versus 4% hydroquinone cream for treatment of facial melasma
/ CompletedNot Applicable An open label, observational, non-interventional, unicentric, clinical investigation to evaluate the efficacy and safety of woman ISDIN Vaginal Moisturizer on symptomatic vaginal atrophy in 43 post menopausal woman during 12 weeks in the alleviation of vaginal atrophy symptoms
/ CompletedNot Applicable Clinical evaluation of a toothpaste formulation including cetyl pyridinium chloride and cymenol: safety, clinical efficacy and microbiological impact and patient perception
100 Clinical Results associated with ISDIN SA
0 Patents (Medical) associated with ISDIN SA
100 Deals associated with ISDIN SA
100 Translational Medicine associated with ISDIN SA